Publication | Closed Access

Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: A multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction

Regenerative MedicineStem CellsHematologyStem Cell TransplantationStem Cell ResearchStem-cell TherapyLate IntracoronaryMedicineMesenchymal Stem CellCardiologySingle-blind TrialAcute Myocardial InfarctionHealth Sciences